Strides acquires Sandoz

Strides agreed to acquire Sandoz. Reported deal value: $12M. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Basel, Basel-City, Switzerland.

This page summarizes publicly available information about the transaction as of 2026-03-17. Figures and status may change as filings and press coverage update.

Mumbai: Strides Pharma International AG , a step‑down subsidiary of Bengaluru-based Strides Pharma Science , has entered into definitive agreements with Sandoz AG , Switzerland and its group entities for acquisition and in‑licensing of a portfolio of branded generic products across sub‑Saharan Africa .The initial consideration for the transaction is $12 million, payable at closing and is expected to be funded through internal accruals, Strides said in a statement